Perspective Therapeutics, Inc.
CATX· NYSE
CATXPerspective Therapeutics, Inc.
Filed Mar 26, 2025 · 10-K · 85 days after period end · 0000950170-25-045242
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | — | — | — | $1.92M |
| Net Income | -$40.17M | -$24.68M | -$3.27M | -$1.10M |
| EPS Diluted | — | — | — |
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2024 · filed Mar 26, 2025 · 85 d after period end
